It has not received marketing authorisation from any regulatory body.
For patients who did not discontinue GLP-1 RAs, gastric ultrasound may be used to assess residual gastric contents [108]
As growth hormone naturally declines with age, so can the downstream benefits it provides
doi: 10.1007/s11481-017-9752-7 126 ClineBHCosta-NunesJPCespuglioRMarkovaNSantosAIBukhmanYVet al
Yes, MOTS-C can be very beneficial for type 2 diabetics
Comprehensive Lab Testing Legitimate peptide therapy requires baseline and monitoring labs: Before treatment: Hormone panels, metabolic panels, lipids, inflammatory markers, kidney/liver function During treatment: Regular monitoring of relevant biomarkers (IGF-1 for GH peptides, glucose/HbA1c for GLP-1s) Advanced testing when indicated: DUTCH hormone testing, nutrient panels, genetic markers Why this matters: You cant optimize what you dont measure